|1.||Ochiya, Takahiro: 10 articles (01/2015 - 11/2003)|
|2.||Takei, Yoshifumi: 9 articles (04/2015 - 06/2002)|
|3.||Nagahara, Shunji: 8 articles (02/2012 - 01/2004)|
|4.||Takeshita, Fumitaka: 7 articles (01/2015 - 11/2003)|
|5.||Kadomatsu, Kenji: 6 articles (04/2015 - 06/2002)|
|6.||Sano, Akihiko: 5 articles (03/2007 - 01/2004)|
|7.||Honma, Kimi: 4 articles (02/2007 - 01/2004)|
|8.||Hanai, Koji: 4 articles (10/2006 - 01/2004)|
|9.||Minakuchi, Yoshiko: 4 articles (10/2006 - 01/2004)|
|10.||Tanaka, Eiji: 3 articles (05/2015 - 01/2011)|
06/01/2011 - "The present study was performed to evaluate whether implantation of an atelocollagen sponge plus BMSCs is effective for the treatment of vocal fold scarring. "
07/01/1997 - "This study was performed to determine whether the beneficial effect of atelocollagen matrix implantation on the prevention of scar tissue contraction also inhibits the scar's interference with the growth of maxillary bone. "
06/01/2011 - "Implantation of an atelocollagen sponge with autologous bone marrow-derived mesenchymal stromal cells for treatment of vocal fold scarring in a canine model."
12/01/2010 - "This article reviews recent advances in scaffold-based interventions for the treatment of vocal fold scarring, with a particular emphasis on atelocollagen sheet implantation in the vocal fold lamina propria. "
12/01/2010 - "Implantation of atelocollagen sheet for vocal fold scar."
12/01/2013 - "When tumors were measurable, we initiated treatment with control or siVASH2 mixed with atelocollagen, which enveloped the whole tumor. "
02/15/2011 - "Through atelocollagen-mediated delivery of an miR-516a-3p expression vector into orthotopic 44As3 tumors, we documented its feasibility as a treatment agent. "
08/13/2010 - "Furthermore, atelocollagen-mediated systemic administration of siRNAs significantly reduced the growth of tumors that had been subcutaneously xenografted. "
03/01/2008 - "Antitumor activity of one of the selected siRNAs was confirmed by retarded tumor growth of HPV16+ cells in NOD/SCID mice when locally injected in a complex with atelocollagen. "
09/25/2007 - "Moreover, miR-34a also suppressed in vivo growth of HCT 116 and RKO cells in tumors in mice when complexed and administered with atelocollagen for drug delivery. "
|3.||Neoplasm Metastasis (Metastasis)
01/01/2010 - "In the therapeutic bone metastasis model, injection of miR-16 with atelocollagen via tail vein significantly inhibited the growth of prostate tumors in bone. "
08/23/2005 - "Furthermore, atelocollagen-mediated systemic administration of siRNAs such as enhancer of zeste homolog 2 and phosphoinositide 3'-hydroxykinase p110-alpha-subunit, which were selected as candidate targets for inhibition of bone metastasis, resulted in an efficient inhibition of metastatic tumor growth in bone tissues. "
11/01/2003 - "Furthermore, after orthotopic implantation of NEC8 cells, combined treatment with antisense HST-1/FGF-4 ODNs and Atelocollagen significantly inhibited the growth of testicular tumors as well as the incidence of lymph node metastasis. "
09/01/2008 - "PLK-1 siRNA/atelocollagen was also successfully transfected into cells and inhibited the progression of metastases. "
09/01/2008 - "This study shows the efficacy of i.v. administration of PLK-1 siRNA/atelocollagen for liver metastases of lung cancer. "
04/01/2011 - "In conclusion, the ablative fractional resurfacing laser is effective in the treatment of striae distensae and succinylated atelocollagen may also be effective for striae distensae treatment. "
04/01/2011 - "The effect of succinylated atelocollagen and ablative fractional resurfacing laser on striae distensae."
04/01/2011 - "The ablative CO(2) fractional laser is effective in various cutaneous scars and this study was attempted to evaluate the effect of succinylated atelocollagen and ablative CO(2) fractional laser in the treatment of striae distensae. "
01/01/2013 - "The purpose of this study was to determine the efficacy of atelocollagen to deliver siRNA without TLR3 stimulation in the laser-induced choroidal neovascularization (CNV) model. "
01/01/2013 - "Efficient delivery of siRNA by atelocollagen in a murine laser-induced choroidal neovascularization model."
|1.||Small Interfering RNA (siRNA)
|7.||Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
|9.||Messenger RNA (mRNA)
|10.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|4.||Transplantation (Transplant Recipients)